Research programme: Q fever vaccine - EpiVax
Latest Information Update: 14 Jul 2015
At a glance
- Originator EpiVax; Massachusetts General Hospital
- Class RNA vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Q fever
Most Recent Events
- 11 Jun 2015 Early research in Q fever (Prevention) in USA (unspecified route)